SECTIONS
SUBSCRIBE
Managed Care

Search form

  • News
  • Politics & policy
  • Drug management
  • Payers
  • Providers
  • Current Issue
  • More
    • Past issues
    • Value-Based Care
    • Profiles
    • Conversations
    • Tomorrow's Medicine
    • Original research
    • Pharm D Corner
    • Viewpoints
    • Legislation & regulation
    • Contact Us

Most Popular

Long wait time to see an ob/gyn

Women who were new patients waited an average of nearly 24 days to be seen by an ob/gyn, according to research by Athenahealth. In contrast, the new-patient wait to see for an orthopedist was 13 days. Waits for first appointments with primary care physicians, pediatricians, and cardiologists fell in between those two extremes.

Read more

Aetna’s California Case Puts New Focus on Prior Authorization

The CNN story once again puts controversy about prior authorization into the spotlight. But is it necessary to review the entire medical record?

Read more

What Women’s Health Wants in Your Market

Women are a key focus segment for health care organizations both because of the medical services they utilize as individuals and the influence they have on the health care of others. In one survey, 59% of women and 94% of working moms reported making or heavily influencing health care decisions for their entire families.

Read more

Medical Tourism: Once Ready for Takeoff, Now Stuck at the Gate

Denver businessman Thomas Hiland was typical of the medical travel tourist. In 2005, he needed a mitral valve replacement. This was before the ACA’s guaranteed issue mandate, and he could not get health coverage. A nearby hospital quoted him $150,000 for the procedure; other U.S. hospitals priced…
Read more

FDA OKs Three Merck/Pfizer Drugs for Type-2 Diabetes

The FDA has approved three new drugs for type-2 diabetes: Steglatro tablets (ertugliflozin), an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor; Steglujan tablets (ertugliflozin/sitagliptin), the only fixed-dose combination of an SGLT2 inhibitor and the dipeptidyl peptidase-4 inhibitor sitagliptin;…
Read more

Boomers, Millennials Hit Hard by Opioids

Baby boomers and millennials are the hardest hit by the heroin and opioid epidemic. Boomers, born between 1946 and 1964, top the list, having 27% greater chance of dying from prescription opioids than people born in 1977 and 1979, the baseline group. They also have a 33% chance of dying from a heroin overdose.

Read more

François de Brantes axed by Altarum

François de Brantes, whose payment reform organization merged with the Altarum institute about a year ago, has been fired. His last day was Friday. An email from Altarum’s president and CEO, Lincoln Smith, that circulated at the institute, said he had “tremendous respect” for de Brantes but after…
Read more

Deep Brain Stimulation Presents Radical Fix to Dire Opioid Crisis

Cut an inch-long incision into someone’s scalp. Then drill a hole into the skull that’s no bigger than a dime. Insert an electrode directly into the brain that targets the reward center, the nucleus accumbens. Then thread a wire beneath the skin to a pacemaker implanted in the patient’s chest. That’s deep brain stimulation.

Read more

FDA Grants Breakthrough Therapy Designation to Balovaptan for Autism

The FDA has awarded a breakthrough therapy designation to the investigational oral drug balovaptan (previously known as RG7314, Roche), a vasopressin 1a (V1a) receptor antagonist for individuals with autism spectrum disorder (ASD). Balovaptan has shown the potential to improve social interaction and…
Read more

Heated Chemotherapy “Bath” Improves Ovarian Cancer Survival

In women with metastatic ovarian cancer restricted to the abdominal cavity (stage III), hyperthermic intraperitoneal chemotherapy (HIPEC) improves survival with almost no additional side effects, according to research published in the New England Journal of Medicine. The research, led by the Netherlands…
Read more

Finding Our Way To Serving the Underserved

It’s a must because there is a cost to keeping the underserved that way whether that means funding integrated primary care to help people live healthier lives or footing the bill when people get care in the emergency department.

Read more

Earlier Diabetes Increases Mortality

Two men are the same age and they’ve both been diagnosed with type 2 diabetes. One was diagnosed 10 years before the other, though. The man with the earlier onset of type 2 diabetes has about a 30% to 60% greater risk of dying from any cause.

Read more

Why Medicaid Managed Care Is Looking Outside the Traditional Coverage Box

Social factors, like access to healthy food, stable housing, a steady income, and reliable transportation, may have more to do with a sick person getting well than anything that a health plan, doctor, or hospital can do. That’s been well documented by numerous studies and the likes of the World Health…
Read more

‘Your Struggle Is Part of Your Story’ How To Fix Behavioral Health Care

Some of the greatest people who’ve ever lived not only overcame pain and suffering, but achieved their greatness because—rather than in spite—of those conditions. That includes behavioral health as well.

Read more

Take a Bow, Pharma, for the Hepatitis C Drugs

It may be time to take a break, for just a moment, from criticizing drug manufacturers for their price gouging and other sins and allow them to take a victory lap for some good work they have done. In less than four years, the treatment of hepatitis C has gone from failure rates as high as 70% to success…
Read more

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »
Facebook Twitter LinkedIn RSS Feed
  • Contact Us
  • Our History
  • Terms & Conditions of Use Agreement
  • Address and Subscription Changes
  • 2018 Editorial Calendar
  • 2018 Space and Material Due Dates
  • BPA Statement
  • Submitting Original Research
  • Submitting Viewpoints
  • Site Map
  • Contact Webmaster
  • P&T Community
© 2018 MediMedia, an ICON plc company. All rights reserved.